Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Fate Therapeutics Inc. buy Mizuho

Fate Therapeutics Inc.
Start price
€2.37
20.11.23 / 50%
Target price
€7.31
20.11.24
Performance (%)
-14.58%
End price
€2.03
21.11.24
Summary
This prediction ended on 21.11.24 with a price of €2.03. The prediction for Fate Therapeutics Inc. disappointed with a performance of -14.58%. Mizuho has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Fate Therapeutics Inc. -10.234% -10.234% 107.223%
iShares Core DAX® -1.283% 4.209% 7.084%
iShares Nasdaq 100 -3.338% -1.744% 26.177%
iShares Nikkei 225® -4.286% -1.621% 44.320%
iShares S&P 500 -2.311% -0.096% 20.823%

Comments by Mizuho for this prediction

In the thread Fate Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -14.58%
Target price 7.310
Change
Ends at 20.11.24

Fate Therapeutics, Inc. (NASDAQ: FATE) had its price target lowered by analysts at Mizuho from $12.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for FATE provided by MarketBeat

Mizuho 
0
Report Share
20.11.23
In the thread Trading Fate Therapeutics Inc.
Prediction Buy
Perf. (%) -14.58%
Target price 7.310
Change
Ends at 20.11.24

Die von Mizuho gewählte maximale Laufzeit wurde überschritten

Mizuho 
0
Report Share
21.11.24